STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ
HORSHAM, Pa. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates
Unaudited Second Quarter 2019 total revenue of $8.2 million increased 9% year-over-year First half total revenue of $15.6 million increased 12% year-over-year Recurring revenue of $6.0 million increased 16% year-over-year Domestic installed base increased from 754 to 764 sequentially Gross margin
STRATA Skin Sciences to Participate in Canaccord Genuity 39th Annual Growth Conference
HORSHAM, Pa. , July 24, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced
STRATA Skin Sciences Announces Direct Distribution Contract with Kosmo Meditech in Korea
Company expanding globally and introducing recurring business model in Korea HORSHAM, Pa. , July 08, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing
STRATA Skin Sciences to Present at Upcoming Investor Conferences
HORSHAM, Pa. , June 11, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,
STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ
HORSHAM, Pa. , May 17, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences Announces Preliminary First Quarter 2019 Financial Results and Updates
Unaudited First Quarter 2019 total revenue of $7.4 million increased 15% year-over-year Recurring revenue of $5.3 million increased 17% year-over-year Domestic Installed base increased from 746 to 754 sequentially Gross margin improved 13 percentage points year-over-year HORSHAM, Pa.
Strata Skin Sciences Receives Notice of Filing Delinquency from NASDAQ
HORSHAM, Pa. , April 05, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
Unaudited Fourth Quarter 2018 total revenue was $8.1 million, with recurring revenue of $6.0 million, representing a 10.7% increase in installed base utilization HORSHAM, Pa. , April 02, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical
STRATA Skin Sciences to Participate in Oppenheimer’s 29th Annual Healthcare Conference
HORSHAM, Pa. , March 05, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced